HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 53 filers reported holding HARPOON THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $66,000 | -59.0% | 68,115 | -19.1% | 0.00% | – |
| Q2 2022 | $161,000 | -68.6% | 84,234 | -18.4% | 0.00% | – |
| Q1 2022 | $513,000 | -1.2% | 103,267 | +50.3% | 0.00% | – |
| Q4 2021 | $519,000 | -3.2% | 68,689 | +1.2% | 0.00% | – |
| Q3 2021 | $536,000 | -59.1% | 67,871 | -28.2% | 0.00% | – |
| Q2 2021 | $1,310,000 | +113.0% | 94,484 | +221.5% | 0.00% | – |
| Q1 2021 | $615,000 | +20.6% | 29,387 | -4.2% | 0.00% | – |
| Q4 2020 | $510,000 | -4.1% | 30,687 | -2.2% | 0.00% | – |
| Q3 2020 | $532,000 | +50.3% | 31,380 | +46.9% | 0.00% | – |
| Q2 2020 | $354,000 | – | 21,360 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 3,156,699 | $66,038,000 | 15.37% |
| MPM ASSET MANAGEMENT LLC | 3,238,306 | $67,745,000 | 13.09% |
| MPM BioImpact LLC | 3,898,422 | $81,555,000 | 10.25% |
| Aquilo Capital Management, LLC | 1,554,199 | $32,514,000 | 5.88% |
| Altium Capital Management LP | 199,607 | $4,176,000 | 1.16% |
| SECTORAL ASSET MANAGEMENT INC | 631,050 | $13,202,000 | 1.00% |
| Avidity Partners Management LP | 1,408,000 | $29,455,000 | 0.81% |
| DAFNA Capital Management LLC | 126,663 | $2,650,000 | 0.63% |
| Logos Global Management LP | 300,000 | $6,276,000 | 0.61% |
| Orbimed Advisors | 2,285,704 | $47,817,000 | 0.45% |